Skip to main content

Vivani Medical, Inc.

corporate_fare Company Profile

Vivani Medical, Inc.

Vivani Medical, Inc., a clinical-stage biopharmaceutical company, engages in the development of miniaturized and subdermal drug implants that treat chronic diseases. The company uses its NanoPortal implant technology to develop and potentially commercialize drug implant candidates in the treatment of chronic disease and medication non-adherence. Its pipeline includes NPM-115, a high-dose exenatide implant candidate is in clinical stage development for the treatment of chronic weight management in patients with obesity or overweight; NPM-119, an exenatide implant candidate is in preclinical stage development for the treatment of patients with type 2 diabetes; NPM-139, a miniature and subdermal GLP-1 implant in development for chronic weight management; and OKV-119, an exenatide implant for metabolic diseases in cats. The company is headquartered in Alameda, California.

Exchange: NASDAQSector: Industrial Applications And Services

show_chartPrice Chart

Loading chart...

feed VANI - Latest Insights

VANI
Apr 16, 2026, 6:30 AM EDT
Filing Type: 4
Importance Score:
9
VANI
Mar 26, 2026, 4:36 PM EDT
Filing Type: 8-K
Importance Score:
8
VANI
Mar 26, 2026, 4:35 PM EDT
Source: Wiseek News
Importance Score:
8
VANI
Mar 26, 2026, 4:32 PM EDT
Filing Type: 10-K
Importance Score:
7
VANI
Mar 26, 2026, 4:16 PM EDT
Source: GlobeNewswire
Importance Score:
9
VANI
Mar 16, 2026, 6:15 AM EDT
Filing Type: 4
Importance Score:
9
VANI
Jan 28, 2026, 10:01 AM EST
Filing Type: 4
Importance Score:
9
VANI
Jan 27, 2026, 4:11 PM EST
Filing Type: 8-K
Importance Score:
9
VANI
Jan 27, 2026, 6:01 AM EST
Filing Type: 424B5
Importance Score:
7
VANI
Jan 20, 2026, 9:00 AM EST
Filing Type: 4
Importance Score:
8